Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
topic_facet:"Phase: Phase 3"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (314)
1
Reparixin 1200 mg three times a day as add-on therapy to standard of care to limit disease progression in hospitalised adult patients with COVID-19 and other community-acquired pneumonia. : Reparixin 1200 mg three times a day as add-on therapy to standard of care to limit disease progression in hospitalised adult patients with COVID-19and other community-acquired pneumonia. A multinational, multicentre, randomised, double-blinded, placebo-controlled, parallel-group phase IIItrial. (REPAVID-22)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Reparixin 1200 mg three times a day as add-on therapy to standard of care to limit disease progression in hospitalised adult patients with COVID-19 and other community-acquired pneumonia. : Reparixin 1200 mg three times a day as add-on therapy to standard of care to limit disease progression in hospitalised adult patients with COVID-19and other community-acquired pneumonia. A multinational, multicentre, randomised, double-blinded, placebo-controlled, parallel-group phase IIItrial. (REPAVID-22)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Short Title: Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC)INSIGHT 012 : An International Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19 - Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Phase 3 blinded study to assess the efficacy and safety of Favipiravir vs placebo in Non-critical Hospitalized Patients with COVID-19 Pneumonia (PROVIR) : A Phase 3, Multicenter, Prospective, Placebo-Controlled, Randomized, Double-Blind Study to Assess the Efficacy and Safety of Favipiravir in Non-critical Hospitalized Patients with COVID-19 Pneumonia (PROVIR) - PROVIR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A phase I/III study to assess pre-exposure prophylaxis of AZD5156 in immunocompromised individuals : A Phase I/III Randomized, Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing Immune Impairment - SUPERNOVA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Short Title: Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC)INSIGHT 012 : An International Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19 - Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A Phase 3 blinded study to assess the efficacy and safety of Favipiravir vs placebo in Non-critical Hospitalized Patients with COVID-19 Pneumonia (PROVIR) : A Phase 3, Multicenter, Prospective, Placebo-Controlled, Randomized, Double-Blind Study to Assess the Efficacy and Safety of Favipiravir in Non-critical Hospitalized Patients with COVID-19 Pneumonia (PROVIR) - PROVIR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A phase I/III study to assess pre-exposure prophylaxis of AZD5156 in immunocompromised individuals : A Phase I/III Randomized, Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing Immune Impairment - SUPERNOVA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Therapeutics for Inpatients with COVID-19 (TICO) : A Multicentre, Adaptive, Randomised, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeuticsfor Hospitalised Patients with COVID-19Short Title: Therapeutics for Inpatients with COVID-19 (TICO)INSIGHT Protocol Number: 014 / ACTIV-3 - Therapeutics for Inpatients with COVID-19 (TICO)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
MK4482-013 Phase 3 Study for Prevention of COVID-19 in Adults : A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-4482 for the Prevention of COVID-19 (Laboratory-confirmed SARS-CoV-2 Infection With Symptoms) in Adults Residing With a Person With COVID-19 - MK-4482 Phase 3 Study for Prevention of COVID-19 in Adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 3
Medienart
314
Aufsätze
314
E-Artikel
314
E-Ressourcen
Zeitschriftentitel
314
WHO International Clinical Trials Registry Plat...
Thema
314
610
Phase: Phase 3
314
Recruitment Status: Authorised-recruitment may ...
314
Study Type: Interventional
18
Medical Condition: COVID-19;Therapeutic area: D...
12
Medical Condition: COVID-19 infection MedDRA ve...
10
Medical Condition: COVID-19 MedDRA version: 23....
10
Medical Condition: Healthy Volunteers, with or ...
10
Medical Condition: moderate COVID-19 infection ...
6
Medical Condition: COVID-19 (Coronavirus Diseas...
6
Medical Condition: COVID-19 MedDRA version: 23....
6
Medical Condition: COVID-19 infection MedDRA ve...
6
Medical Condition: Prophylaxis of COVID-19 MedD...
4
Medical Condition: COVID-19 MedDRA version: 20....
4
Medical Condition: COVID-19 MedDRA version: 23....
4
Medical Condition: COVID-19 associated cytokine...
4
Medical Condition: COVID-19 severe pneumonia, a...
4
Medical Condition: Coronavirus disease 2019 (CO...
4
Medical Condition: Mild to Moderate coronavirus...
4
Medical Condition: SARS-COV-2 infection MedDRA ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
8
2023
50
2022
122
2021
134
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
304
Englisch
6
Unbestimmt
2
Deutsch
2
Polnisch
Haven't found what you're looking for?
Wird geladen...